Acquisition method (AMC)
0
FSC 6505 × AMPICILLIN AND SULBACTAM FOR INJ
AMPICILLIN AND SULBACTAM FOR INJ
6505-01-275-2568 FSC 6505
NSN 6505-01-275-2568 (also written 6505012752568; NIIN 01-275-2568) is an ampicillin and sulbactam for inj in Federal Supply Class 6505, Drugs and Biologicals. 18 manufacturer part numbers from 8 suppliers are on record. It was last purchased in Oct 2026.
Open for bid
No open solicitations on record for this NSN right now.
Can you win it?
The codes on record do not say whether this item is competed or bought from a named source.
Suffix (AMSC)
0
Competition
—
AMC 0: not established: the part has not completed screening. AMSC 0 The codes describe the item's status on record, not any one solicitation. What the codes mean
What it is — can you make it?
Dimensions, the FLIS specification requirements, and the manufacturer part numbers already qualified against this NSN.
Specifications
From the federal catalog (DLA FLIS / PUB LOG) — what your part has to meet. Cited specification documents can be looked up in ASSIST Quick Search ↗, DoD's public spec repository — copy the document number in.
| Requirement | Value |
|---|---|
| PHYSICAL FORM AGXW | POWDER |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH AKJA | GRAMS AMPICILLIN EQUIVALENT 2.000 AND GRAMS SULBACTAM ACTIVE INGREDIENT 1.000 |
| PRIMARY CONTAINER TYPE CQCT | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY CRLK | GRAMS OF ACTIVE INGREDIENT 3.000 |
| TOTAL PRIMARY CONTAINER QUANTITY CSCW | 10 |
| ADMINISTRATION CSGS | INTRAMUSCULAR AND INTRAVENOUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY CXCY | AMPICILLIN SODIUM AND SULBACTAM SODIUM STERILE 3GM VIAL 10S |
| SPECIAL FEATURES FEAT | VIAL SIZE: 20 ML. EACH 3 G VIAL CONTAINS: 3 GRAMS OF AMPICILLIN AND SULBACTAM FOR INJECTION (EQUIVALENT TO 2 GRAMS OF AMPICILLIN AS THE SODIUM SALT PLUS 1 GRAM OF SULBACTAM AS THE SODIUM SALT). PRIOR TO RECONSTITUTION, STORE DRY POWDER AT 20-25 DEG C (68-77 DEG F)(SEE USP CONTROLLED ROOM TEMPERATURE) |
| MEDICAL DESIGNATION AND GRADE MDES | UNITED STATES PHARMACOPEIA |
Manufacturer part numbers
Commercial part numbers cross-referenced to this NSN in the federal catalog — the parts that have been accepted as satisfying this stock number, and who makes them.
| Part number | CAGE | Manufacturer |
|---|---|---|
| 10024319 | 1XUY5 | AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP |
| 10083576 | 1XUY5 | AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP |
| 10125059 | 1XUY5 | AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP |
| 10170543 | 1XUY5 | AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP |
| 306920 | 57KZ6 | FRESENIUS KABI, LLC |
| F009992972 | 86491 | PFIZER INC |
| NDC00049-0014-83 | 07TA6 | CARDINAL HEALTH 200, LLC |
| NDC00049-0014-83 | 1XUY5 | AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP |
| NDC00049-0014-83 | 86491 | PFIZER INC |
| NDC00641-6117-10 | 32655 | HIKMA PHARMACEUTICALS USA INC. |
| NDC25021-0143-30 | 1XUY5 | AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP |
| NDC25021-0143-30 | 4RP13 | SAGENT PHARMACEUTICALS, INC DBA SAGENT PHARMACEUTICALS, INC |
| NDC44567-0211-10 | 1XUY5 | AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP |
| NDC44567-0211-10 | 6XJQ8 | WG CRITICAL CARE, LLC |
| NDC63323-0369-20 | 57KZ6 | FRESENIUS KABI, LLC |
| NDC67457-0349-10 | 1XUY5 | AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP |
| NDC67457-0349-10 | 3KJG9 | MYLAN PHARMACEUTICALS INC |
| UNASYN 3G | 86491 | PFIZER INC |
What it pays — so you can quote
The government's own price and demand record for this NSN — what past awards cleared at, so you know where to land your quote.
Latest unit price
—
Purchases
0
Total spend
—
Oct 27, 2026
Last purchased
3 · 3.0/yr
Purchase records
$170.03
Total demand
$72.87
Latest award total
Purchase history
No priced purchases on record for this NSN yet.
Related contract actions
Contract action totals, not unit prices — obligation amounts from USAspending for related awards, shown for context only. These do not appear on the price chart above.
| Action date | Award # | Recipient | Agency | Obligation |
|---|---|---|---|---|
| Aug 6, 2026 | SPE2DX25D9822/SPE2D226F3197 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $72.87 |
| Aug 19, 2026 | SPE2DX25D9822/SPE2D226F3290 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $24.29 |
| Oct 27, 2026 | SPE2DX25D9822/SPE2D227F0053 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $72.87 |
Demand history
Who wins this item
Does one supplier win this every time, and are the winners on the listed-source list? One dot per award.
- Award in the last 2 years
- Older award
DMS PHARMACEUTICAL GROUP INC
last award Oct 2026
AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP
no award yet
no awards on record
Listed source CARDINAL HEALTH 200, LLC
no award yet
no awards on record
Listed source FRESENIUS KABI, LLC
no award yet
no awards on record
Listed source HIKMA PHARMACEUTICALS USA INC.
no award yet
no awards on record
Listed source MYLAN PHARMACEUTICALS INC
no award yet
no awards on record
Listed source PFIZER INC
no award yet
no awards on record
Listed source SAGENT PHARMACEUTICALS, INC DBA SAGENT PHARMACEUTICALS, INC
no award yet
no awards on record
Listed source DMS PHARMACEUTICAL GROUP INC won 3 of the last 3 awards. DMS PHARMACEUTICAL GROUP INC won without being a listed source.
Open RFQs on DIBBS → DIBBS award history ↗
About this data
- Unit prices: DLA DIBBS award records — every row links to its government record.
- AMSC: latest observed value from DIBBS solicitation history as of Oct 28, 2026.
- Contract action totals: USAspending, context only.
- Data last refreshed: 2026-11-06.
- Full methodology →
Cite this page
Citation
NSN Explorer. "AMPICILLIN AND SULBACTAM FOR INJ." nsnexplorer.com, https://nsnexplorer.com/nsn/6505-01-275-2568/. Data as of November 7, 2026.
Link
https://nsnexplorer.com/nsn/6505-01-275-2568/